Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia. (2017)

First Author: Huang B
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.16975

Publication URI: https://www.repository.cam.ac.uk/handle/1810/270145

Type: Journal Article/Review